CommentaryToo much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond
Under an Elsevier user license
open archive
Cited by (0)
© 2015, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics